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Abstract 60 
Objective: Develop a generic trans-disciplinary, skills-based capability framework for health 61 
professionals providing care for people with OA. 62 
Design: e-Delphi survey. An international inter-professional Delphi Panel (researchers; clinicians; 63 
consumer representatives) considered a draft framework (adapted from elsewhere) of 131 specific 64 
capabilities mapped to 14 broader capability areas across four domains (A: person-centred approaches; 65 
B: assessment, investigation and diagnosis; C: management, interventions and prevention; D: service 66 
and professional development). Over three rounds, the Panel rated their agreement (Likert or numerical 67 
rating scales) on whether each specific capability in Domains B and C was essential (core) for all 68 
health professionals when providing care for all peopl  with OA. Those achieving consensus (≥80% of 69 
Panel) rating of ≥ seven out of ten (Round 3) were retained. Generic domains (A and D) were included 70 
in the final framework and amended based on Panel comments. 71 
Results: 173 people from 31 countries, spanning 18 disciplines and including 26 consumer 72 
representatives, participated. The final framework comprised 70 specific capabilities across 13 broad 73 
areas i) communication; ii) person-centred care; iii) h story-taking; iv) physical assessment; v) 74 
investigations and diagnosis; vi) interventions and care planning; vii) prevention and lifestyle 75 
interventions; viii) self-management and behaviour change; ix) rehabilitative interventions; x) 76 
pharmacotherapy; xi) surgical interventions; xii) referrals and collaborative working; and xiii) 77 
evidence-based practice and service development). 78 
Conclusion: Experts agree that health professionals require an array of skills in person-centred 79 
approaches; assessment, investigation and diagnosis; management, interventions and prevention; and 80 
service and professional development to provide optimal care for people with OA.  81 
  82 
Introduction  83 
Osteoarthritis (OA), particularly of the knee and hip is the 12th highest contributor to global disability 84 
in adults aged 50-69 years1. Around 240 million people (1 in 11) have OA, with a substantial increase 85 
expected in the future2. Osteoarthritis can be debilitating, with pain being the dominant symptom that 86 
often becomes persistent and more limiting as OA progresses3. Physical function can become 87 
increasingly impaired over time, impacting substantially on quality of life and ability to participate in 88 
social, leisure and occupational activities3. Management of people with OA typically involves a wide 89 
range of clinicians, including medical practitioners, an array of allied health professionals, and span  90 
primary to tertiary care settings4. Unfortunately, current care for people with OA is variable and 91 
frequently inconsistent with clinical guideline recommendations. A meta-analysis of studies evaluating 92 
community-based care in developed countries for people with OA, based on adherence to evidence-93 
based quality indicators, showed a median overall pass rate of 41%5. Alarmingly, the pass rates for core 94 
first-line OA treatments (such as exercise, education and weight control) were below 40%. 95 
Osteoarthritis is highly prevalent in low- and middle-income countries6, and it is likely that the quality 96 
of care received by people with OA in these countries is also sub-optimal7.  97 
 98 
A major contributor to the quality of care received by people with OA is the capability of the healthcare 99 
workforce to deliver care that is aligned with evidence-based recommendations and a biopsychosocial 100 
approach to management8. Clinicians feel ‘under-prepared’ to manage OA, lacking knowledge about 101 
recommended practice and/or how to implement recommendations into routine care as well as the skills 102 
to support patients to make lifestyle changes (such as exercise or weight loss)9,10. This is particularly 103 
important given that common misconceptions about knee OA influence patients’ acceptance of non-104 
surgical evidence-based treatments11. A “capability” may be defined as an integration of knowledge, 105 
skills, personal qualities and understanding used appropriately and effectively- not just in familiar nd 106 
highly focused specialist contexts, but in response to new and changing circumstances12.  107 
 108 
Defining the core capabilities of health professionals delivering care for people with OA is required to 109 
inform improvements to pre-licensure curricula and to ensure professional development programs are 110 
appropriately targeted to workforce needs13. This is particularly relevant in contemporary healthcare, 111 
where skills are often no longer unique to one healt  professional group14 and innovative service re-112 
design is advocated for implementation of OA evidence-based recommendations into practice15. 113 
Although a UK framework exists for first point of contact musculoskeletal practitioners16 and EULAR 114 
has recommendations about generic core competencies for nurses, physiotherapists and occupational 115 
therapists in rheumatology17, there is no framework describing the core capabilities generic to all health 116 
professionals specifically for OA management. 117 
 118 
This study aimed to develop a generic trans-disciplinary, skills-based core capability framework for 119 
health practitioners to optimise care for people with OA, using consumer participation and an 120 
international inter-professional consensus process. The framework is intended to be applicable to all 121 




We established a Delphi Panel and conducted an e-Delphi survey between February and April 2019 to 126 
achieve expert consensus on the core capability framework. The study was overseen by an international 127 
inter-professional Steering Group, established by the International Osteoarthritis Management 128 
Programs ‘Joint Effort’ Initiative endorsed by OARSI in 201818. A Steering Group of 14 members 129 
from Australia, USA, UK, Netherlands, Denmark, France and Sweden and comprising physiotherapists 130 
(RSH; KLB; AMB; JPE; STS; KSD; ME), rheumatologists (DJH; SPY; AW; FB), an orthopedic 131 
surgeon (LED), an exercise physiologist (KDA) and a consumer with OA (NB), was convened.  Ethical 132 
approval was obtained from the University of Melbourne. Fig 1 overviews the study phases. 133 
 134 
Survey development 135 
In the formative phase, the Steering Group debated whether the final framework should be discipline-136 
specific, or more generic and thus relevant to all health professionals who may provide care to people 137 
with OA. The Group recognised the array of health professions involved in OA care, in a wide variety 138 
of healthcare settings across countries, and with variable access to different health disciplines. To 139 
maximise generalisability, the Group decided upon a capability framework generic to all health 140 
professionals, which could provide a “scaffold” for professional groups to expand (if necessary) into 141 
specialised capability frameworks for specific health professions. 142 
 143 
The Steering Group selected the “Musculoskeletal core apabilities framework for first point of contact 144 
practitioners” recently published by the Health Education England, Skills for Health and NHS England, 145 
UK16 for adaptation in the current study. This framework describes the capabilities that are applicable 146 
to clinicians with a role as a first point of contact for adults presenting with undiagnosed 147 
musculoskeletal conditions. It consists of 105 specific apabilities (mapped to 14 broader capability 148 
areas) across four domains, two describing more ‘generic’ capabilities relevant for all clinical 149 
encounters irrespective of health condition (Domain A: person-centred approaches; Domain D: service 150 
& professional development) and two describing capabilities relevant to assessment, care planning and 151 
management of patients with musculoskeletal conditions (Domain B: assessment, investigation and 152 
diagnosis; Domain C: management, interventions and prevention) and amenable to tailoring for a 153 
specific musculoskeletal condition.   154 
 155 
With permission from Skills for Health, the Steering Group revised the specific capabilities to ensure 156 
they were as specific and relevant to OA as much as pos ible (rather than musculoskeletal conditions 157 
more broadly), and to acknowledge the varying scope and roles of health professionals involved in OA 158 
care. To do this, the Steering Group considered other relevant frameworks19,20, used their knowledge of 159 
research evidence as well as their clinical expertis . For example, “Understand the role of common 160 
rehabilitative interventions for musculoskeletal conditions” was revised to “Understand the role of 161 
common rehabilitative interventions including pain education, therapeutic exercise, weight loss, 162 
manual therapy, cognitive behavioural approaches, aids nd assistive devices, orthotic, braces and 163 
splints for managing OA, based on the best available evidence” and “Understand the role of joint 164 
injections, informed by the evidence base, in musculoskeletal practice” was revised to “Understand the 165 
role of intra-articular injections in managing OA (including corticosteroids, platelet rich plasma, 166 
hyaluronic acid and stem cells), based on best available evidence”. The Steering Group also suggested 167 
12 additional capabilities for inclusion (mapping each to the most relevant broad capability area based 168 
on consensus of opinion, Appendix 1) and re-ordered th  broad groupings of capabilities in a flow 169 
better suited to OA care. One specific capability was excluded as it was outside the scope of a 170 
capability framework for OA (Domain B:  Diagnose common problems that can usually be managed at 171 
the first point of contact) and another was excluded b cause re-wording of other capabilities rendered it 172 
redundant (Domain C: Advise on the effects of smoking, obesity and inactivity on musculoskeletal 173 
health and conditions and, where appropriate promote change or refer to relevant services). 174 
 175 
Delphi Panel 176 
An international inter-professional Delphi Panel of experts (including Steering Group members) was 177 
established to reach consensus on a framework of capabilities, comprising: 178 
a) Health professionals involved in OA human research ( esearchers); 179 
b) Health professionals who provide clinical care for people with OA (clinicians); and 180 
c) Consumer representatives. 181 
 182 
Inclusion criteria for researchers were i) qualified and registered health professional and; ii) at lest 183 
one of the following a) first or last author on at least two papers per year on primary human research 184 
in OA in the past five years or; b) invited to give a plenary or keynote presentation on OA at an 185 
international conference in the last five years. Inclusion criteria for clinicians were i)  registered to 186 
practice as a health professional in their home country; and ii) have managed, on average, at least one 187 
patient with OA per week over the past six months. Inclusion criteria for consumer representatives 188 
were currently employed by an arthritis consumer advocacy organisation and/or previous diagnosis of 189 
OA from a doctor. All Panel participants understood English. 190 
 191 
A list of potential Panel participants was developed by the Steering Group, drawing from their 192 
academic, research and clinical networks, the OARSI membership, and the field of published OA 193 
research. This was supplemented by an internet search of arthritis consumer advocacy organisations 194 
internationally. Potential Panel members were invited to participate via email (n=976 invitations sent). 195 
We also advertised for additional clinicians using advertisements in social media (Facebook). 196 
Potentially eligible Panellists completed a series of creening questions embedded at the beginning of 197 
the Round 1 e-Delphi survey to ensure they fulfilled the eligibility criteria. Ineligible volunteers were 198 
not admitted to the Delphi Panel and did not complete the Round 1 e-Delphi survey. For subsequent 199 
Delphi rounds, only those participants who had completed the preceding Delphi round were emailed 200 
the survey.  201 
 202 
e-Delphi Survey 203 
The Delphi Panel were asked to rate the specific capabilities in Domains B (assessment, investigation 204 
and diagnosis) and C (management, interventions and prevention) only. This was to reduce the time 205 
burden on Panellists in completing iterative surveys and to focus efforts on the domains where opinions 206 
on “core” capabilities were likely to vary the most. In addition, the Steering Committee determined a 207 
priori that the more generic Domains A (person-centred approaches) and D (service & professional 208 
development) were core capabilities relevant to all health professionals and people with all health 209 
conditions, and thus should automatically be included in the final framework, given they had already 210 
been validated in another Delphi process16. However, the Delphi Panel was invited to provide optional 211 
feedback on specific capabilities within these domains t the end of Round 1 if they wished. The survey 212 
was constructed using SurveyGizmo (SurveyGizmo; Colorado), an online survey software tool and 213 
administered iteratively over three rounds (Fig 1), with two weeks between each. Each round was open 214 
for 2 weeks, with three reminder emails sent over that ime to non-responders to encourage completion. 215 
Each round took approximately 30-40 minutes to complete. 216 
 217 
Round 1 218 
In Round 1, the Panel was asked to rate each specific capability (in Domains B and C) as either “not 219 
important” “somewhat important” “important” or “essential” to the care of people with OA.  They were 220 
invited to add new capabilities not already included in the draft framework (which were later mapped 221 
by the Steering Group to the most relevant broad capability area based on consensus of opinion). 222 
Specific capabilities that reached Panel consensus (defined as at least 80% of the Panel to ensure only 223 
the “core” capabilities remained and considering that 75% is a median threshold of consensus21) as 224 
“important” or “essential” were retained for further consideration in Round 2.  225 
 226 
Round 2 227 
In Round 2, the Panel was asked to reconsider and rate the capabilities retained from Round 1, as well228 
as any new capabilities identified by the Panel in Round 1. Summary Panel data from Round 1 229 
(presented as n (%) across response categories) were provided against each capability to assist in this 230 
process. For this Round, each Panel member was asked to rate how much they agreed/disagreed that 231 
each capability was essential (core) for ALL health professionals when providing care for ALL people 232 
with OA. Panel members were prompted to think about the wide range of health professionals involved 233 
in providing healthcare for people with OA (e.g. physicians, surgeons, nurses, physiotherapists, 234 
dieticians etc), and the wide variation in clinical presentation of people with OA. Panellists rated their 235 
level of agreement on an 11-point numerical rating scale (ranging from 0=strongly disagree to 236 
10=strongly agree). Only capabilities that achieved a consensus (at least 80% of Panel) rating of at least 237 
six were retained for Round 3.   238 
 239 
Round 3 240 
In Round 3, the Panel was asked to reconsider and rate the capabilities retained from Round 2 using the 241 
same rating scale as Round 2. Panel summary data from Round 2 (presented as n (%) rating 4 or below; 242 
5-6; 7-8 and; 9-10) were provided for consideration. O ly capabilities that achieved a consensus (at 243 
least 80% of Panel) rating of seven or more were retain d for inclusion in the final framework22.  244 
 245 
At the end of the e-Delphi Survey process, the Steering Group considered the free text optional 246 
comments provided by the Delphi Panel on Domains A and D in Round 1, with a view to amending the 247 
text and/or merging or removing capabilities, based on the feedback received. 248 
 249 
Consumer involvement 250 
A consumer was a member of the project Steering Group. As a research partner23, the role of the 251 
consumer was to provide input at all stages, with a particular focus on reviewing capabilities included 252 
in the draft survey (including inserting additional capabilities if required), participating in the Delphi 253 
Panel, advising on content and design of the infographics for communicating key findings, as well as 254 
reviewing and co-authoring the manuscript. 255 
 256 
Results 257 
Table 1 describes the Delphi Panel. In Round 1, 173 participants from 31 different countries spanning 258 
18 different health professions and including 26 (15%) consumer representatives participated. Over 259 
half of the Panel (58%) were currently involved in clinical care of people with OA. We retained 131 260 
Panel members for Round 2 and 118 Panel members for Round 3 (Table 1, Fig 1), representing 76% 261 
and 68% retention of the initial (Round 1) Panel respectively. 262 
 263 
Fig 1 summarises outcomes of each Delphi Round. In Round 1, 19 (21%) specific capabilities did not 264 
reach consensus as being “important” or “essential” for inclusion in Domains B and C of the core 265 
capability framework for health professionals managi g people with OA and were excluded from 266 
Round 2 (Appendix 2). Furthermore, 34 individual members Panel suggested additional capabilities for 267 
consideration, generating an additional 17 unique capabilities for inclusion into Round 2. A total of 34 268 
Panel members provided optional feedback on the genric capabilities within Domains A and D. This 269 
feedback was used to amend wording of 10 specific capabilities. The Steering Group merged six 270 
specific capabilities into three under Domain A to reduce redundancy. In Round 2, 23 (26%) specific 271 
capabilities did not reach consensus agreement for retaining in Round 3 (Appendix 3) and were thus 272 
excluded from the final round. In Round 3, 17 (25%) of capabilities considered across Domains B and 273 
C did not achieve Panel consensus for retention in the final capability framework and were excluded 274 
(Appendix 4). The final core capability framework comprised 70 specific capabilities mapped to 13 275 
broader capability areas (Table 2, summarised in Fig 2).  276 
 277 
Discussion  278 
This study aimed to develop a generic trans-disciplinary, skills-based core capability framework for 279 
health professionals who deliver care to people with OA, using an international inter-professional 280 
consensus process. This framework is a model that communicates the key capabilities required of 281 
health professionals to ensure excellence in best practice OA care. The final framework comprised 70 282 
specific capabilities mapped to 13 broader capabilities i) communication; ii) person-centred care; iii) 283 
history-taking; iv) physical assessment; v) investigations and diagnosis; vi) interventions and care 284 
planning; vii) prevention and lifestyle interventions; viii) self-management and behaviour change; ix) 285 
rehabilitative interventions; x) pharmacotherapy; xi) surgical interventions; xii) referrals and 286 
collaborative working; and xiii) evidence-based practice and service development, across four 287 
domains.  288 
 289 
Our framework was adapted from an existing UK musculoskeletal capability framework16. There are 290 
thus many similarities across the two, particularly regarding Domains A (person-centred approaches) 291 
and D (service and professional development), which remain largely unchanged in our framework for 292 
managing OA. Our framework does not include the broader capability area of injection therapy, 293 
probably because of the limited role that injections have in managing a subset of people with OA24. In 294 
contrast to the musculoskeletal framework, which was developed for first point of contact practitioners 295 
who require advanced skills in diagnosis and management across a range of diseases, our framework 296 
is intended solely for those health professionals who manage people with OA, which probably 297 
explains why ours comprises 33% fewer specific capabilities (70 versus 105). Patient-reported 298 
outcomes25 and objective measures of physical function26 are widely advocated in hip and knee OA 299 
management, and capabilities relating to these wereincluded in the draft framework by the Steering 300 
Group at the formative phase (Appendix 1). It is thus surprising that these capabilities did not reach a 301 
consensus for inclusion in the final framework. It is unclear why these items were excluded. Many of 302 
these measures have been developed, validated and endors d primarily for knee, and to a lesser extent, 303 
hip OA, and experts may have considered them less important in the context of all patients with OA 304 
(which may involve the hand, foot or spine for example) or healthcare settings where measurement of 305 
these is impractical for all. 306 
 307 
As our framework is not specific to any health discipline, we acknowledge that different professional 308 
groups may bring specialist knowledge and/or skills in addition to the core set. Specific professional 309 
groups may wish to validate our work in the future by subjecting our OA capability framework to a 310 
similar Delphi or other consensus process, which may le d to the inclusion of additional capabilities, 311 
or exclusion of others as appropriate for the different health professions involved in OA care. In 312 
addition, many of the capabilities within the framework have relevance to clinicians managing patients 313 
with other health conditions, particularly those with chronic conditions, where lifestyle strategies 314 
(exercise and weight control), pain control, prevention, self-management, rehabilitation and behaviour 315 
change are critical. Thus, our framework may be suited for future adaptation in other chronic 316 
conditions, such as low back pain, for example. It adds to the growing body of work articulating 317 
competencies for training of European rheumatologists27, in pain assessment and management for 318 
prelicensure health professionals19, of nurses, physiotherapists and occupational therapists in 319 
rheumatology17  and in health promotion and prevention of non-communicable diseases for 320 
physiotherapists28, all of which serve to increase capability of the healthcare workforce. 321 
 322 
Contemporary models of OA care demand a workforce of adequate volume capable of delivering 323 
safe, effective, evidencebased care (i.e. highvalue care)8. This includes knowledge and skills to 324 
disinvest in ineffective (lowvalue) care. This is particularly important given the misconceptions held 325 
by people with OA that ultimately influence acceptance of first-line (non-surgical) evidence-based 326 
treatments such as exercise and weight loss11. A skilled workforce is required to combat inapproriate 327 
beliefs about OA and empower individuals to engage with effective evidence-based interventions. A 328 
survey of general practitioners, physiotherapists and nurses in Australia, New Zealand and Canada 329 
showed that 37-88% of clinicians and 68-85% of students perceived that their knowledge and skills 330 
were barriers to implementing OA care29. Skills gaps were evident regarding assessment, measur ment 331 
and monitoring; exercise and nutritional/overweight management; supporting positive behaviour 332 
change; tailoring care; managing case complexity; and translating knowledge to practice. Confidence in 333 
OA knowledge and skills was consistently greatest among physiotherapists and lowest in primary care 334 
nurses30. These findings are supported by qualitative research10 showing rheumatologists, orthopedic 335 
surgeons, physiotherapists and general practitioners p rceive a lack of healthcare provider expertise as 336 
a major barrier to providing non-pharmacological, non-surgical OA care. Suboptimal organization of 337 
care, including inadequate inter-professional communication and lack of clarity about roles and 338 
responsibilities of disciplines, is also a barrier10. Recognising these problems, Australia’s National 339 
Strategic Action Plan for Arthritis31 has prioritised the need to define skill sets and competencies for 340 
arthritis management and care across clinical discipl nes, care settings, and levels of professional 341 
practice, in order to identify educational needs across professions, including general practitioners, 342 
nurses, allied health professionals and pharmacists. Thi  study addresses this important priority with 343 
relevance to nations beyond Australia.  344 
 345 
Strengths of our study include our large Delphi Panel, with high retention. We assembled 173 experts  346 
and retained two-thirds of them through all three survey rounds. There is no agreement on ideal Delphi 347 
panel size32. For example, a systematic review of 80 Delphi studies reported a median panel size of 17, 348 
with a minimum of 3 and a maximum of 418 members33. Thus, our Delphi panel may be considered 349 
large. Importantly, over half of the Panel were active clinicians involved in care of people with OA. 350 
Another strength of our Panel was its diversity, comprising experts from 31 different countries, 351 
spanning 18 different health professions and including 26 consumer representatives. Panel breadth 352 
ensured the final framework was relevant to a range of health professions, spanning first contact 353 
primary care though to tertiary management, across the globe. However, our Panel did not include 354 
experts from South Asia or Sub-Saharan Africa or low-income or lower-middle-income economies34, 355 
which may be due to the requirement that Panellists be fluent in English. This limits the generalisability 356 
of our framework to culturally and linguistically diverse populations, and to low and middle-income 357 
countries where health worker cadres differ to those f high-income settings. Our framework is non-358 
specific to the joint affected by OA. Although this increases the generalisability of the capability 359 
framework to the wider population of people with OA, it is possible that particular sub-groups of 360 
people with OA (e.g. those with hand OA) may benefit from additional core capabilities. 361 
 362 
Our Panel comprised more physiotherapists and rheumatologists relative to other professions. Best 363 
practice management of OA may require clinical expertis  from a range of health professionals to 364 
accommodate individual patient needs, however people with OA experience substantial challenges in 365 
accessing treatment, including difficulty obtaining referrals and appointments, long waiting times and366 
limited availability of primary and specialist care in some areas35. The under-representation of some 367 
professions in our Panel may be partially related to our inclusion criteria, whereby clinicians were 368 
required to have managed at least one patient with OA per week over the past six months to qualify as 369 
an “expert”. It is likely that few pain physicians, psychologists and dieticians (for example) could meet 370 
such criteria, due to the difficulties experienced by patients with OA in accessing care from these 371 
professions. Nonetheless, the framework outlines a core set of capabilities to ensure that any health 372 
professional managing OA is able to implement evidence-based pathways, either directly themselves or 373 
as part of an integrated multi-professional team. The core capability framework is not intended to 374 
dictate what any clinician should be doing within their specialist scope of practice. Rather, it aims to et 375 
a common standard across all professionals involved in OA care, at any point on the care pathway, 376 
across the disease spectrum and across healthcare settings. 377 
 378 
Implementation of the core capability framework into the OA health workforce requires a multi-faceted 379 
approach (including but not limited to endorsement by discipline-specific professional bodies, 380 
integration into pre-licensure curricula and focused training for the current workforce) across 381 
stakeholders including higher education, public andprivate healthcare and professional and consumer 382 
advocacy sectors. The framework is intended as a reference guide to be applied according to local 383 
priorities and needs. For example, in higher education, he framework may be used to audit, develop 384 
and refine pre-licensure educational curricula for health professionals, as well as guide assessment of 385 
learning. Private and public health service managers may use the framework when recruiting and 386 
training staff to deliver OA services, by identifying and articulating the skills required of individuals, 387 
including those employed in advanced practice roles and/or working as part of a broader integrated 388 
multi-disciplinary OA management “program”. The framework may be used at the level of individual 389 
clinicians as a self-evaluation tool to identify are s for personal professional development. This core390 
capability framework will be used by the International Osteoarthritis Management Programs ‘Joint 391 
Effort’ Initiative of OARSI18  to inform the future development of strategies for training and 392 
educational activities. Implementation of this framework will likely encounter similar barriers 393 
experienced by clinical guidelines36, including clinician factors (e.g. knowledge of and attitudes 394 
towards the framework, self-efficacy, motivation and confidence to change behaviours), framework-395 
related factors (e.g. complexity, accessibility and pplicability) and external factors (e.g. organizational 396 
constraints, healthcare funding models).  397 
 398 
Conclusions 399 
To provide optimal care for all people with OA, health professionals require a diverse array of skills in 400 
person-centred approaches; assessment, investigation and diagnosis; management, interventions and 401 
prevention; and service and professional development. Implementation of the core capability 402 
framework will help individual health professionals and organisations identify training and 403 
development needs of the OA workforce, ultimately improving the quality of care and effectiveness of 404 
OA services and improving outcomes for people with OA.  405 
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Table 1: Characteristics of the Delphi Panel. 544 






Type of expert, n (%) 
     Researcher 
     Clinician 
     Clinician researcher 
















    
Health profession, n (%)† 
     Physiotherapist 
     Rheumatologist 
     Orthopaedic surgeon 
     General practitioner/family physician 
     Sport & exercise medicine physician 
     Dietician 
     Podiatrist 
     Radiologist 
     Chiropractor 
     Pain physician 
     Athletic trainer 
     Diagnostic radiographer 
     Exercise physiologist 
     Nurse 
     Occupational therapist 
     Orthotist 
     Osteopath 




 9 (6) 
 7 (4) 
 4 (3) 
 3 (2) 
 3 (2) 
 3 (2) 
 2 (1) 
 2 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 







































              
Country of residence, n (%)    
     Australia 
     United States 
     United Kingdom 
     Netherlands 
     Canada 
     Denmark 
     France 
     China 
     Malaysia 
     Norway 
     Spain 
     Brazil 
     Ireland 
     Japan 
     New Zealand 
     Belgium 
     Czech Republic 
     Germany 
     Greece 
     Hungary 
     Israel 
     Italy 
     Lebanon 
     Malta 
     Poland 
     Portugal 
     Romania 
     Serbia 
     Singapore 
     Sweden 





 9 (5) 
 6 (3) 
 6 (3) 
 4 (2) 
 4 (2) 
 4 (2) 
 3 (2) 
 2 (1) 
 2 (1) 
 2 (1) 
 2 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 
 1 (1) 































































†n=147 health professional members of Delphi panel in Round 1; n= 114 in Round 2; n= 104 in Round 3 545 
  546 
Table 2. The core capability framework for health professionals involved in the clinical care of people with osteoarthritis. 
 
DOMAIN A: Person-centred approaches 
Capability 1. Communication 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Apply a critical self-awareness of their own values, beliefs, prejudices, assumptions and stereotypes especially related to pain and overweight/obesity to   
   mitigate the impact of these in how they interact with others. 
b) Listen to and communicate with others, recognising that both are an active, two-way process. 
c) Modify conversations to optimise engagement and understanding, and convey information in ways that avoid jargon, negative or potentially threatening descriptors and   
   assumptions. 
d) Respond to individuals’ communication and information needs by adapting communication style (verbal and non-verbal) and supporting the use of   
   accessible information as needed. 
e) Engage with individuals and carers and respond appropriately to questions and concerns about their OA and its impact on their current situation and  
   potentially in the future. 
f)   Direct individuals appropriately and effectively to sources of accurate and reliable information and support. 
g)  Communicate efficiently and effectively with colleagues to serve individuals’ best interests and to expedite and integrate care. 
h)  Respect and draw on colleagues’ knowledge and expertise within the inter-disciplinary team (where available) to serve individuals’ best interests. 
Capability 2. Person-centred care 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Recognise the expertise that individuals bring to managing their own care, demonstrating sensitivity to the individuals’ background, identity, language, culture, resources, 
values, needs, preferences and experiences of pain and functional limitations related to OA.  
b) Explore the impact of persistent pain and disability on individuals’ lives, including on their relationships, family and social roles, self-esteem and ability to participate in 
what they need and want to do (including paid and upaid work). 
c) Take account during care planning of the burden (fiancial and time) of treatment for individuals with OA, including regular appointments that may also be for the 
management of their other healthcare needs. 
d) Progress care, recognising that meaningful positive outcomes (such as restoring and maintaining functio  and independence, and improving quality of life) may be 
achieved without a reduction in pain (whilst preferable). 
e) Enable individuals to make decisions about their care by: 
· empowering them to identify the priorities and outcomes that are important to them and supporting them to set goals 
· explaining in non-technical language all available options (including doing nothing), and the evidence base underpinning the interventions 
· exploring with them the risks, benefits and consequences of each available option and discussing what these mean in the context of their life and goals 
DOMAIN B: Assessment, Investigation & Diagnosis 
Capability 3. History-taking 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Listen to individuals, ask questions and obtain appro riate additional information, with due sensitivity and consideration of what information needs   
      to be sought to optimise the effectiveness and efficiency of the subjective examination. 
b) Gather and synthesise information on the nature of the individual’s symptoms taking account of how these issues relate to the presenting and past  
     history, their activities, any prior injuries, falls, frailty, comorbidities or other determinants of health and the characteristics of OA. 
c) Assess patient preferences and values to determine pa -related goals and priorities. 
d) Assess the impact of individuals’ presenting symptoms on their quality of life, including the impairment of function, limitation of activities and  
      restriction on participation, including work, social roles and relationships. 
e) Gather information on the treatments the individual has previously undertaken to manage their OA sympto s, including whether these were  
     effective or ineffective. 
f) Record the information gathered through taking individuals’ history concisely and accurately for clinical management, and in compliance with  
      local protocols, legal and professional requirements. 
Capability 4. Physical assessment 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Appropriately obtain individuals’ consent to physical examination, respect and maintain their privacy, dignity and comfort, as far as practicable,  
      and comply with infection prevention and contr l procedures. 
b) Adapt their practice to meet the needs of different groups and individuals (including cultural and religious factors, and those with particular needs  
      such as cognitive impairment or learning disabilities), working with care-givers, where appropriate. 
c) Undertake observational and functional assessments of individuals, relevant to their OA and problem(s), to identify and characterise any  
          impairments. 
d) Record the information gathered through assessments co cisely and accurately, for clinical management and in compliance with local protocols,  
       legal and professional requirements. 
     Capability 5. Investigations and diagnosis 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Understand that diagnosis of OA is based on clinical presentation (symptoms) rather than structural chnges observed on imaging, and that routine use of imaging is not 
necessary for a clinical diagnosis of OA. 
b) Assess the importance and meaning of presenting features from the clinical assessment, recognising the wid  variation in how OA may manifest. 
c) Identify potential serious pathology and make approriate onwards referral. 
d) Identify risk factors for symptomatic, functional and/or structural OA progression. 
e) Recognise and act where an early referral and diagnosis may be particularly important for optimising individuals’ long-term outcomes. 
f) Recognise how OA and its impact can interact with other comorbidities (eg mental health, cardiovascular disease, obesity), and identify when this is relevant. 
g) Use accurate and non-threatening language in talking about the diagnosis of OA, including avoidance of phrases such as ‘wear and tear’, ‘grinding’, and ‘bone on bone’. 
DOMAIN C: Management, Interventions & Prevention 
Capability 6. Interventions and care planning 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Work in partnership with the individual to develop management plans that take account of individuals’ needs, goals, preferences, local service  
       availability and relevant guidelines. 
b) Recognize that different types of pain (nociceptive, neuropathic, nociplastic) may require different management approaches. 
c) Identify pain treatment options that can be accessed by the individual in a comprehensive pain management plan. 
d) Ensure the management plan considers all options that are appropriate for the care pathway, as well as the benefits and risks of available treatments,  
      and the underlying evidence for each. 
e) Advise on pharmacological and non-pharmacological aspects of pain management. 
f) Review management plans regularly, including monitori g of the individual’s symptoms and effectiveness and tolerability of treatments, and adjust the  
      plan of care as needed. 
Capability 7. Prevention and lifestyle interventions 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Advise on the effects of inactivity on OA, promote participation in physical activity (that is appropriate for and acceptable to the individual), and refer to relevant services 
where appropriate. 
b) Advise on the effects of overweight and obesity on OA (including risk of OA development), promote weight management, and refer to relevant services where appropriate. 
c) Use interactions to encourage changes in behaviour that can have a positive impact on the health and wellbeing of individuals, communities and populations. 
d) Facilitate behaviour change using evidence-based appro ches that support self-management. 
Capability 8. Self-management and behaviour change 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Explain how health promotion and self-management stra egies are important to the management of pain. 
b) Support individuals to self-manage and fulfil their role in their management plan, and where appropriate use principles of behaviour change theory and patient activation, to 
optimise their physical activity, mobility, fulfilment of personal goals and independence relevant to their OA. 
c) Support individuals to explore the consequences of their actions and inactions on their health status nd the fulfilment of their personal health goals (e.g. their engagement in 
exercise and their use of medication). 
d) Support individuals to get the most from conversations about the management of their OA and its impacts (e.g. loss of independence) by supporting and encouraging them 
to ask questions about what is a priority or concer fo  them. 
e) Identify risk factors for the persistence and impact of OA on pain and functional ability. 
Capability 9.  Rehabilitative interventions 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Understand the role of common rehabilitative interventions, including pain education, therapeutic exercis , weight loss, manual therapy, cognitive behavioural approaches, aids 
and assistive devices, orthotics, braces and splint for managing OA, based on best available evidence. 
b) Advise on the expected benefits, limitations and risks of different rehabilitative interventions used in managing OA, providing impartial information and a vice on the 
advantages and disadvantages of specific interventions in the context of other management options. 
c) Provide advice on managing pain and optimising functio , including graded activity, navigation to self- management resources, and activity pacing. 
d) Understand that some individuals such as those living with mental health issues, co-morbidities or frailty might need additional support during rehabilitation. 
e) Work in partnership with individuals to explore suitability of rehabilitation interventions, including community- based exercise programmes where appropriate. 
f) Refer individuals to specialist rehabilitation practitioners (e.g. physiotherapists, dieticians, occupational therapists, psychologists) where this is appro riate. 
Capability 10. Pharmacotherapy 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Understand the role of medications used in managing OA, including acetaminophen, non-steroidal anti-inflammatory drugs, corticosteroids and  
     opioids, based on best available evidence. 
b) Refer for advice about pharmacotherapy, when considered appropriate. 
Capability 11. Surgical interventions 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Understand the role of arthroscopy and arthroplasty in managing OA, based on best available evidence. 
b) Advise on the expected benefits, limitations and risks of arthroscopy and arthroplasty in managing OA (where these are relevant to individuals’ 
     care) and inform them impartially on the advantages and disadvantages in the context of other management options. 
c) Refer for surgical opinion when an appropriate course of non-surgical management does not provide sufficient control of pain. 
Capability 12. Referrals and collaborative working 
When managing people with OA, the health professional can do the following: 
a) Practise within their professional and personal scope of practice and access specialist advice or support for the individual or for themselves when  
      appropriate. 
b) Engage in effective inter-professional communication and collaboration with clear documentation to optimise the integrated management of the  
      individual with OA. 
c) Engage in effective inter-professional communication and collaboration to optimise care for OA within the population. 
d) Know and be able to draw on the expertise of all memb rs of the inter-disciplinary team and social support to meet individuals’ best interests and  
      optimise the integration of their care. 
e) Contribute effectively to inter-disciplinary team activity (including service delivery processes and learning and development). 
f)  Participate as an effective team member and understand the importance of effective team dynamics. 
g) Make appropriate referrals using appropriate documentation to other health and care professionals and agencies when this is in individuals’ best  
      interests. 
DOMAIN D:  Service & Professional Development 
Capability 13. Evidence-based practice and service development 
Within their role and scope of professional practice in OA, the health professional can do the following: 
a) Critically apply relevant national clinical practice guidelines and other best available evidence on OA care and service delivery, identifying where local modifications may be 
required. 
b) Monitor and evaluate their practice and its outcomes, including through data collection and analysis to assure and improve the quality of OA care, servic delivery and 
address health inequalities. 
c) Engage in the distinct activities of clinical audit, service evaluation and research (leading or contributing, as appropriate) adhering to the national ad local requirements, and 
regulatory frameworks that relate to each. 
d) Seek input from individuals and their carers to improve the person-centred design and quality of servic s. 
e) Act appropriately when service deficiencies are identifi d (e.g. frequent long waiting times) that have the potential to affect the effective management of individuals’ OA 
care, including by taking or advocating for corrective action, where needed. 
f) Plan, engage in and record learning and development relevant to their role and in fulfilment of professional, regulatory and employment requirements. 
g) Engage in reflective practice and clinical supervision as an integral part of their professional development and to inform OA service development and quality improvement 
with reference to local needs. 
  
Appendix 1: Additional capabilities suggested by the Steering Group in the survey formative phase  
Overarching broad capability  Specific capability  
# 3- History taking  - Assess patient preferences and values to determine pain-related goals and priorities. 
- Administer and score patient-reported outcome measures to assess pain, and the impact of OA on function, informed by an 
understanding of the measures’ respective validity, reliability, specificity and sensitivity in people with OA. 
- Gather information on the treatments the individual has previously undertaken to manage their OA sympto s, including 
whether these were effective or ineffective. 
#4- Physical assessment - Apply outcome measures of physical performance that enable objective measurement of physical function, informed by an 
understanding of the measures’ respective validity, reliability, specificity and sensitivity in people with OA.  
#5- Investigations & diagnosis - Understand that dignosis of OA is based on clinical presentation (symptoms) rather than structural changes observed on 
imaging, and that routine use of imaging is not necessary for a clinical diagnosis of OA. 
#6- interventions & care-planning -Understand how contextual factors may influence the magnitude of treatment effects on OA symptoms, in order to optimize 
outcomes of management. 
- Identify pain treatment options that can be accessed by the individual in a comprehensive pain management plan. 
- Review management plans regularly, including monitoring of the individual’s symptoms and effectiveness and tolerability of 
treatments, and adjust the plan of care as needed. 
#8- Self-management & behaviour change - Explain the complex, multidimensional and individual-specific nature of pain to the individual. 
- Explain how health promotion and self-management strategies are important to the management of pain.
- Help individuals manage the psycho-social implications of OA. 
#9- Rehabilitative interventions - Suggest the use of digital technology (e.g. apps and wearables) to deliver treatment and support adherenc . 
  
Appendix 2: Capabilities excluded after Round 1 
 
Overarching broad capability  Specific capability excluded 
# 3- History taking  - Administer and score patient-reported outcome measures to assess pain, and the impact of OA on function, informed by an 
understanding of the measures’ respective validity, reliability, specificity and sensitivity in people with OA. 
- Critically appraise complex, incomplete, ambiguous and conflicting information presented by individuals, distilling and 
synthesising key factors from the appraisal, and identifying those elements that may need to be pursued further. 
#4- Physical assessment - Apply outcome measures of physical performance that enable objective measurement of physical function, informed by an 
understanding of the measures’ respective validity, reliability, specificity and sensitivity in people with OA.  
#5- Investigations & diagnosis - Instigate appropriate investigative tests to aid diagnosis and assessment. 
#7- Prevention & lifestyle interventions - Appraise the impact that a range of social, economic, and environmental factors can have on outcomes for indivduals with 
OA, their carers and their circles of support. 
- Recognise and promote the importance of social networks and communities for individuals and their caers in living well with 
OA. 
- Advise individuals and relevant agencies on how OA-related work loss can be prevented through acting o  effective risk 
assessments and providing appropriate working conditi s, including adaptation to meet the individual’s needs. 
#8- Self-management & behaviour change - Advise on and refer individuals to psychological therapies and counselling services, in line with their needs, taking account of 
local service provision. 
- Advise individuals on the effects of their OA and their response to it, including the causal links between absence from work, 
prolonged absence, reduced return to work and subseq ent loss of employment. 
- Advise and assist individuals to identify and usestrategies to address work instability and to improve work retention. 
- Advise on sources of relevant local or national self-help guidance, information and support including coaching. 
#9- Rehabilitative interventions - Suggest the use of digital technology (e.g. apps and wearables) to deliver treatment and support  adherence. 
- Make recommendations to employers regarding indivduals’ fitness to work, including through seeking of appropriate 
occupational health advice. 
#10- Pharmacotherapy - Identify sources of further information (e.g. websites or leaflets) and advice (e.g. pharmacists) and be able to signpost 
individuals as appropriate to complement the advice g v n. 
- Keep individuals’ response to medication under review, recognising differences in the balance of risks and benefits that may 
occur in the context of polypharmacy, multimorbidity, frailty and cognitive impairment. 
#11- Injection therapy - Advise on the expected benefits, limitations and risks of injection therapy for managing OA and inform individuals 
impartially on its advantages and disadvantages in the context of other management options. 
- Work in partnership with individuals to explore the suitability of injection therapy, addressing and seeking to allay 
individuals’ fears, beliefs and concerns. 
- Refer for advice about local injections, when considered appropriate. 
#13 Referrals & collaborative working - Advise on local non-clinical services that individuals and their carers may benefit from accessing to help manage OA and its 
impact, including those relating to employment, voluntary activities, counselling services and leisure facilities. 
 
Appendix 3: Capabilities excluded after Round 2 
 
Overarching broad capability  Specific capability excluded 
#4- Physical assessment - Select and conduct an appropriate initial musculoskeletal screening assessment. 
- Apply a range of physical assessment techniques appropriately, systematically and effectively, informed by an understanding 
of techniques’ respective validity, reliability, specificity and sensitivity in people with OA and the implications of the 
limitations they may have within an assessment. 
- Assess multi-directional three-dimensional movement pat erns 
#5- Investigations & diagnosis - Understand how OA may be a manifestation of injury not only from trauma but also abuse, recognising particular at-risk 
groups (such as older people with frailty and those with cognitive impairment) and take appropriate action when there are 
grounds for concern. 
- Understand and interpret test results and act appropriately, demonstrating an understanding of the indications and limitations 
of different tests to inform decision-making. 
- Interpret radiographs. 
#6- Interventions & care planning - Advise on the links between OA symptoms and reduced mental well-being and refer individuals to sources of mental health 
support when in their best interests. 
- Understand the importance of joint load management in a patient-specific context 
#7- Prevention & lifestyle interventions - Understand the role of different weight reduction strategies, based on best available evidence. 
#8- Self-management & behaviour change - Explain the complex, multidimensional and individual-specific nature of pain to the individual. 
- Recognise in their management approach that OA is often coupled with mental health issues, frailty, multimorbidity or other 
determinants of health. 
- Help individuals manage the psycho-social implications of OA. 
- Use an understanding of contemporary pain biology in order to deliver evidence-based and accurate pain education. 
- Use motivational interviewing principles to engage and empower people with OA to self-manage according to evidence-based 
guidelines. 
- Advise on social welfare and sources of financial support. 
- Understand the important link between the language used to describe OA and how it may adversely impact in perception 
and self-management behaviours. 
#9- Rehabilitative interventions - Prescribe tailored (personalised) rehabilitation programmes to helpindividuals enhance, restore and maintain their mobility, 
function and independence. 
- Manufacture custom-made orthoses. 
- Prescribe and modify an appropriate exercise program (including dosage) according to individual needs, considering potential 
barriers to adherence. 
- Provide advice on optimising function, including goal-orientated functional movement strategies. 
- Provide advice on managing pain and optimising function, including strategies to reduce joint loading. 
#11- Injection therapy - Appreciate that patients without an effusion will require guidance by imaging (fluoroscopy or ultrasound) to ensure adequate 
placement of intra articular injections. 
#14- Evidence-based practice & service 
development 
- Work within the constraints of the health service, including the time available for consultations and the resources available. 
 
  
Appendix 4: Capabilities excluded after Round 3 
 
Overarching broad capability  Specific capability excluded 
#3- History taking - Gather and synthesise information on the nature of individuals’ issues from various appropriate sources e.g. previous histories 
and investigations, considering how symptoms of OA may manifest as pain, stiffness, weakness, fatigue, limitation of activities, 
restriction of participation, sleep disturbance andmood disorders 
- Explore and appraise with individuals’ perceptions, ideas or beliefs about their pain and OA and whether these may act as a 
driver or form a barrier to improvement. 
- Appraise factors affecting individuals’ ability to participate in life situations, including work and social activities, and their 
perceptions of the relationship between their work and health. 
- Critically appraise information obtained, taking account of the potential for OA symptoms to be features of other health 
conditions, compounded by psychological and mental he th factors, and affected by lifestyle factors (including 
overweight/obesity and physical inactivity). 
#4- Physical assessment - Identify, analyse and interpret potentially significant information from the physical assessment (including any ambiguities). 
#6- Interventions & care planning - Understand how c ntextual factors may influence the magnitude of treatment effects on OA symptoms, in order to optimize 
outcomes of management. 
- Advise on and instigate a management plan for OA-instigating this may be through referral to digital management programs 
and/or to other practitioners with specific relevant capabilities. 
- Identify when first-line intervention has been successful and discharge the patient with appropriate advice. 
#7- Prevention & lifestyle interventions - Advise on the effects of joint injury on risk of OA, promote injury-prevention strategies, and refer to relevant services where 
required. 
- Advise individuals living with frailty and their carers how to adapt the physical environment to promote independence, 
orientation and safety (e.g. to reduce risk of falls). 
- Work collaboratively across agencies and boundaries to improve OA-related health outcomes and reduce health inequalities. 
- Develop a personalised physical activity plan to assist the individual to meet recommended levels of physical activity. 
#8- Self-management & behaviour change - Advise indiv duals on how limitations of activities and restric ion of participation associated with OA can be reduced through 
adaptations to meet the individual’s needs. 
#10- Pharmacotherapy - Use their understanding of the most common medications used in OA to advise individuals on the pharmacological 
management of their OA, the expected benefits, limitations and risks, and inform them impartially on the advantages and 
disadvantages in the context of other management options. 
- Address and seek to allay individuals’ fears, beliefs and concerns 
#11- Injection therapy - Understand the role of intra-articular injections in managing OA (including corticosteroids, platelet rich plasma, hyaluronic 
acid and stem cells), based on best available evidence. 
#12- Surgical interventions - Work in partnership with individuals to explore suitability of surgical intervention, discussing individuals’ fears, beliefs and 










“Musculoskeletal core capabilities framework for first 
point of contact practitioners”16 
Domain A- 2 broad; 16 specific capabilities 
Domain B- 3 broad; 25 specific capabilities 
Domain C- 8 broad; 57 specific capabilities 
Domain D- 1 broad; 7 specific capabilities 
Domain A- 2 broad; 16 specific capabilities 
Domain D- 1 broad; 7 specific capabilities 
Comments against each 
specific capability provided 
(n=34 respondents) 
 
Final core capability framework: 
Domain A- 2 broad; 13 specific capabilities 
Domain B- 3 broad; 17 specific capabilities 
Domain C- 7 broad; 33 specific capabilities 
Domain D- 1 broad; 7 specific capabilities 
 
 
17 (25 % of 67 considered) specific capabilities 
excluded: 
Domain B- 5 excluded 
    
 
 
Merged 6 specific capabilities into 3 (Domain A) 
Amended wording of 10 specific capabilities 
(Domains A & D) 
19 (21% of 92 considered) specific capabilities excluded: 
Domain B- 4 excluded 
Domain C- 15 excluded 
17 new specific capabilities generated: 
Domain B- 3 included 
Domain C- 13 included 
Domain D- 1 included 
23 (26 % of 90 considered) specific capabilities excluded: 
Domain B- 6 excluded 
Domain C- 16 excluded 
Domain D- 1 excluded 
Steering Committee adaptation  
Domain B- 3 broad; 29 specific capabilities 
Domain C- 8 broad; 63 specific capabilities 
 
Round 1 e-Delphi (n= 173 participants) 
Round 2 e-Delphi (n= 131 participants, 76% Round 1) 
Round 3 e-Delphi (n= 118 participants, 68% Round 1) 
Optional open text comments invited in 
Round 1 e-Delphi (n= 173 participants) 
Steering Committee review 
 
Figure 2: Infographics summarising the core capability framework for health professionals 
involved in the clinical care of people with osteoarthritis.  
  
